S100A2 downregulation is significantly associated with poor differentiation, tumor invasion, and lymph node metastasis in vivo [93,94,95], and unfavorable survival in patients with gastric cancer in vivo [93,94]. This evidence concerns the gene S100A2 and gastric cancer.